Session Information
2010 Midyear Clinical Meeting
Click here to go to the previous page
Assuring Safe Technology Implementation in Specialty Areas: Pediatrics, Oncology, and Investigational Drug Services
Track: Education Sessions (CE)
Program Code: 235-L05
Date: Tuesday, December 7, 2010
Time: 2:00 PM to 4:00 PM EST
Location: Room 207A, Level 2
PRESENTER(S):
Sylvia Bartel, RPh, MPH, Director of Pharmacy, Dana Farber Cancer Institute
Craig Kwiatkowski
 Jeannell Mansur, PharmD, Practice Leader, Medication Safety, Joint Commission Resources
Kim Redic
PROGRAM CHAIR:   Click the plus sign to see more detailed information about each speaker.
 Jeannell Mansur, PharmD, Practice Leader, Medication Safety, Joint Commission Resources

  • Describe three features of pediatric medication order entry that require specialized builds or designs.
  • Explain the scope of investigational drug medication processes which technology should be designed to support.
  • List five technology safety features that support chemotherapy medication safety.
  • List four general assessment areas of technology functionality that could impact medication safety.


Audio Synchronized to PowerPoint
(Code: 235-L05)
Attendee: Free
  
This session is a part of:
Handout Online
View